نتایج جستجو برای: boost vaccination

تعداد نتایج: 84560  

Journal: :Journal of virology 2007
Robert De Rose C Jane Batten Miranda Z Smith Caroline S Fernandez Viv Peut Scott Thomson Ian A Ramshaw Barbara E H Coupar David B Boyle Vanessa Venturi Miles P Davenport Stephen J Kent

Vaccination against AIDS is hampered by great diversity between human immunodeficiency virus (HIV) strains. Heterologous B-subtype-based simian-human immunodeficiency virus (SHIV) DNA prime and poxvirus boost vaccine regimens can induce partial, T-cell-mediated, protective immunity in macaques. We analyzed a set of DNA, recombinant fowlpox viruses (FPV), and vaccinia viruses (VV) expressing sub...

2015
Bruna de Andrade Pereira Leoneide E. Maduro Bouillet Natalia A. Dorigo Cornel Fraefel Oscar Bruna-Romero Welkin E. Johnson

Recombinant human adenovirus serotype 5 (HAd5V) vectors are gold standards of T-cell immunogenicity as they efficiently induce also humoral responses to exogenous antigens, in particular when used in prime-boost protocols. Some investigators have shown that pre-existing immunity to adenoviruses interferes with transduction by adenoviral vectors, but the actual extent of this interference is not...

2016
Rachel Buglione-Corbett Rachel Mari Buglione-Corbett

In recent years, heterologous prime-boost vaccination constructs have emerged as a promising strategy to generate broad and protective immunity against a variety of pathogens. The utility of DNA vaccination in priming the immune system, in particular, has improved the immunogenicity of vaccines against difficult pathogens such as HIV1. In addition, many vaccine formulations include an adjuvant ...

2013
Rachel Mari Buglione-Corbett

In recent years, heterologous prime-boost vaccination constructs have emerged as a promising strategy to generate broad and protective immunity against a variety of pathogens. The utility of DNA vaccination in priming the immune system, in particular, has improved the immunogenicity of vaccines against difficult pathogens such as HIV1. In addition, many vaccine formulations include an adjuvant ...

2016
Hannah J. Metcalfe Sabine Steinbach Gareth J. Jones Tim Connelley W. Ivan Morrison Martin Vordermeier Bernardo Villarreal-Ramos

There is a need to improve the efficacy of Bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans and cattle. Previously, we found boosting BCG-primed cows with recombinant human type 5 adenovirus expressing antigen 85A (Ad5-85A) increased protection against Mycobacterium bovis infection compared to BCG vaccination alone. The aim of this study was to decipher aspects of the im...

2009
George Jiang Meng Shi Solomon Conteh Nancy Richie Glenna Banania Harini Geneshan Anais Valencia Priti Singh Joao Aguiar Keith Limbach Kurt I. Kamrud Jonathan Rayner Jonathan Smith Joseph T. Bruder C. Richter King Takafumi Tsuboi Satoru Takeo Yaeta Endo Denise L. Doolan Thomas L. Richie Walter R. Weiss

Using newer vaccine platforms which have been effective against malaria in rodent models, we tested five immunization regimens against Plasmodium knowlesi in rhesus monkeys. All vaccines included the same four P. knowlesi antigens: the pre-erythrocytic antigens CSP, SSP2, and erythrocytic antigens AMA1, MSP1. We used four vaccine platforms for prime or boost vaccinations: plasmids (DNA), alphav...

2012
Tess L. Killpack William H. Karasov

Based on studies from the poultry literature, all birds are hypothesized to require at least 4 weeks to develop circulating mature B-cell lineages that express functionally different immunoglobulin specificities. However, many altricial passerines fledge at adult size less than four weeks after the start of embryonic development, and therefore may experience a period of susceptibility during th...

Journal: :Vaccines 2023

With concerns about the efficacy of repeat annual influenza vaccination, it is important to better understand impact priming vaccine immunity and develop an effective vaccination strategy. Here, we determined heterologous prime-boost on inducing broader protective compared with same antigen. The primed mice that were intramuscularly boosted a inactivated A virus (H1N1, H3N2, H5N1, H7N9, H9N2) s...

Journal: :PLoS ONE 2007
Ansar A. Pathan Clare R. Sander Helen A. Fletcher Ian Poulton Nicola C. Alder Natalie E. R. Beveridge Kathryn T. Whelan Adrian V. S. Hill Helen McShane

OBJECTIVES To investigate the safety and immunogenicity of boosting BCG with modified vaccinia Ankara expressing antigen 85A (MVA85A), shortly after BCG vaccination, and to compare this first with the immunogenicity of BCG vaccination alone and second with a previous clinical trial where MVA85A was administered more than 10 years after BCG vaccination. DESIGN There are two clinical trials rep...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید